Relief Therapeutics Holding AG (RLFTF)
USD 4.9
(0.0%)
USD 4.9
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -98.18 Million CHF | -93.31% |
| 2022 | -50.79 Million CHF | -46.35% |
| 2021 | -34.7 Million CHF | -343.34% |
| 2020 | -7.82 Million CHF | -4.93% |
| 2019 | -7.46 Million CHF | -1611.01% |
| 2018 | -436 Thousand CHF | 84.9% |
| 2017 | -2.88 Million CHF | 82.85% |
| 2016 | -16.83 Million CHF | -83.89% |
| 2015 | -9.15 Million CHF | 25.46% |
| 2014 | -12.28 Million CHF | -0.89% |
| 2013 | -12.17 Million CHF | -87.69% |
| 2012 | -6.48 Million CHF | 89.04% |
| 2011 | -59.16 Million CHF | -205.03% |
| 2010 | -19.39 Million CHF | -58.81% |
| 2009 | -12.21 Million CHF | -29.92% |
| 2008 | -9.4 Million CHF | -369.97% |
| 2007 | -2 Million CHF | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.27 Million CHF | 0.0% |
| 2024 Q1 | -2.27 Million CHF | 94.53% |
| 2023 Q1 | -28.24 Million CHF | -16.3% |
| 2023 FY | -98.18 Million CHF | -93.31% |
| 2023 Q2 | -56.49 Million CHF | -100.0% |
| 2023 Q4 | -41.68 Million CHF | -100.0% |
| 2023 Q3 | -20.84 Million CHF | 63.11% |
| 2022 Q2 | -26.5 Million CHF | -100.0% |
| 2022 FY | -50.79 Million CHF | -46.35% |
| 2022 Q3 | -12.14 Million CHF | 54.17% |
| 2022 Q4 | -24.29 Million CHF | -100.0% |
| 2022 Q1 | -13.25 Million CHF | 33.84% |
| 2021 FY | -34.7 Million CHF | -343.34% |
| 2021 Q3 | -10.01 Million CHF | 31.78% |
| 2021 Q4 | -20.02 Million CHF | -100.0% |
| 2021 Q2 | -14.67 Million CHF | -100.0% |
| 2021 Q1 | -7.33 Million CHF | 54.36% |
| 2020 Q2 | 8.25 Million CHF | 100.0% |
| 2020 Q1 | 4.12 Million CHF | 159.76% |
| 2020 Q3 | -8.03 Million CHF | -197.44% |
| 2020 FY | -7.82 Million CHF | -4.93% |
| 2020 Q4 | -16.07 Million CHF | -100.0% |
| 2019 Q2 | -556 Thousand CHF | -100.0% |
| 2019 Q3 | -3.45 Million CHF | -520.86% |
| 2019 Q1 | -278 Thousand CHF | -683.1% |
| 2019 Q4 | -6.9 Million CHF | -100.0% |
| 2019 FY | -7.46 Million CHF | -1611.01% |
| 2018 Q4 | -35.5 Thousand CHF | 0.0% |
| 2018 FY | -436 Thousand CHF | 84.9% |
| 2018 Q3 | -35.5 Thousand CHF | 80.55% |
| 2018 Q2 | -182.5 Thousand CHF | 0.0% |
| 2018 Q1 | -182.5 Thousand CHF | 79.92% |
| 2017 Q3 | -909 Thousand CHF | -70.07% |
| 2017 Q4 | -909 Thousand CHF | 0.0% |
| 2017 Q2 | -534.5 Thousand CHF | 0.0% |
| 2017 FY | -2.88 Million CHF | 82.85% |
| 2017 Q1 | -534.5 Thousand CHF | 93.55% |
| 2016 FY | -16.83 Million CHF | -83.89% |
| 2016 Q1 | -136.5 Thousand CHF | 0.0% |
| 2016 Q3 | -8.28 Million CHF | -5966.3% |
| 2016 Q4 | -8.28 Million CHF | 0.0% |
| 2016 Q2 | -136.5 Thousand CHF | 0.0% |
| 2015 FY | -9.15 Million CHF | 25.46% |
| 2014 FY | -12.28 Million CHF | -0.89% |
| 2013 FY | -12.17 Million CHF | -87.69% |
| 2012 FY | -6.48 Million CHF | 89.04% |
| 2011 FY | -59.16 Million CHF | -205.03% |
| 2010 FY | -19.39 Million CHF | -58.81% |
| 2009 FY | -12.21 Million CHF | -29.92% |
| 2008 FY | -9.4 Million CHF | -369.97% |
| 2007 FY | -2 Million CHF | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -30.973% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -1392.995% |
| SQZ Biotechnologies Company | -79.46 Million USD | -23.554% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 285.321% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 250.739% |
| Mesoblast Limited | -87.95 Million USD | -11.625% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -5292.996% |
| Genus plc | 7.9 Million USD | 1342.797% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -801.426% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -2546.221% |
| Marizyme, Inc. | -65.34 Million USD | -50.246% |
| ContraFect Corporation | -65.15 Million USD | -50.693% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -1010.142% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -1909.409% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -5583.563% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -3294.455% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -1118.175% |
| MultiCell Technologies, Inc. | -380.07 USD | -25832246.673% |
| Accustem Sciences Inc. | -3.74 Million USD | -2520.663% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -89.935% |
| EV Biologics, Inc. | -1.26 Million USD | -7648.273% |
| Q BioMed Inc. | -2.05 Million USD | -4684.432% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -2530.083% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -15424.97% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -4023.745% |
| Biomind Labs Inc. | -1.21 Million USD | -7985.272% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | -830.802% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -1142.311% |
| Skye Bioscience, Inc. | -37.64 Million USD | -160.809% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -4424.858% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -655488.942% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -1306.033% |
| IMV Inc. | -36.48 Million USD | -169.095% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -518.602% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -1587.755% |
| GB Sciences, Inc. | -1.36 Million USD | -7110.3% |
| Alpha Cognition Inc. | -13.77 Million USD | -612.874% |
| HST Global, Inc. | -146.21 Thousand USD | -67050.674% |
| CSL Limited | 2.64 Billion USD | 103.716% |
| Halberd Corporation | -79.67 Thousand USD | -123125.313% |
| Enzolytics Inc. | -2.17 Million USD | -4410.27% |
| Resverlogix Corp. | -3.61 Million USD | -2619.695% |
| Affymax, Inc. | -14.42 Million USD | -580.678% |
| SYBLEU INC | -180.3 Thousand USD | -54353.035% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -2995.79% |
| argenx SE | -295.05 Million USD | 66.724% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -56.841% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 100284.694% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -2371.21% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -3144.436% |
| AVAX Technologies, Inc. | -6.41 Million USD | -1430.814% |
| Zenith Capital Corp. | -10.59 Million USD | -826.586% |
| Genscript Biotech Corporation | -95.47 Million USD | -2.832% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -422329.223% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -2268.126% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -162342.106% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -64.387% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -3065.324% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -9196.941% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -4936.863% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -2470.856% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -4796.527% |
| BioStem Technologies, Inc. | -8.48 Million USD | -1057.388% |
| ONE Bio Corp. | 8.67 Million USD | 1231.559% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -22144.652% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -7252.008% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -5495.089% |
| Agentix Corp. | -1.37 Million USD | -7044.536% |
| LadRx Corporation | 400.44 Thousand USD | 24618.096% |
| Cell Source, Inc. | -5.32 Million USD | -1745.087% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -23530.797% |
| Regen BioPharma, Inc. | 1.02 Million USD | 9692.597% |
| Regen BioPharma, Inc. | 1.02 Million USD | 9692.597% |
| NovAccess Global Inc. | -4.76 Million USD | -1958.653% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 1517.859% |
| Itoco Inc. | -1.86 Million USD | -5153.144% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -2110.022% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -5782.624% |
| Kadimastem Ltd | -3.3 Million USD | -2868.527% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -35810.857% |
| CytoDyn Inc. | -49.84 Million USD | -96.988% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -124127.854% |
| Mobile Lads Corp. | -2.26 Million USD | -4237.973% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -42937.869% |
| Qrons Inc. | -789.34 Thousand USD | -12338.256% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -10327.825% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -4602.871% |
| Rebus Holdings, Inc. | -1.02 Million USD | -9525.588% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -5987.849% |
| International Stem Cell Corporation | -131 Thousand USD | -74847.328% |
| Bioxytran, Inc. | -4.28 Million USD | -2193.948% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -180805.439% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -3780.293% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -104.237% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -4544.324% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -12473.01% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -2999.148% |
| Neutra Corp. | -233.46 Thousand USD | -41953.841% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -383.865% |
| PureTech Health plc | -65.69 Million USD | -49.445% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -361.669% |
| IXICO plc | -1.17 Million USD | -8234.55% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -889.03% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -71.861% |
| CSL Limited | 2.64 Billion USD | 103.716% |
| Cellectis S.A. | -103.17 Million USD | 4.839% |